Barclays’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $588K | Buy |
100,291
+47,228
| +89% | +$277K | ﹤0.01% | 2958 |
|
|
2025
Q1 | $445K | Sell |
53,063
-24,222
| -31% | -$203K | ﹤0.01% | 2912 |
|
|
2024
Q4 | $539K | Sell |
77,285
-2,411
| -3% | -$16.8K | ﹤0.01% | 3004 |
|
|
2024
Q3 | $460K | Buy |
79,696
+62,073
| +352% | +$358K | ﹤0.01% | 3044 |
|
|
2024
Q2 | $118K | Sell |
17,623
-23,423
| -57% | -$157K | ﹤0.01% | 3300 |
|
|
2024
Q1 | $535K | Sell |
41,046
-30,246
| -42% | -$394K | ﹤0.01% | 2793 |
|
|
2023
Q4 | $917K | Buy |
71,292
+54,952
| +336% | +$707K | ﹤0.01% | 2659 |
|
|
2023
Q3 | $199K | Sell |
16,340
-2,934
| -15% | -$35.7K | ﹤0.01% | 3040 |
|
|
2023
Q2 | $475K | Buy |
19,274
+653
| +4% | +$16.1K | ﹤0.01% | 2627 |
|
|
2023
Q1 | $479K | Buy |
18,621
+9,666
| +108% | +$249K | ﹤0.01% | 2669 |
|
|
2022
Q4 | $210K | Buy |
8,955
+7,541
| +533% | +$177K | ﹤0.01% | 3065 |
|
|
2022
Q3 | $32K | Sell |
1,414
-3,654
| -72% | -$82.7K | ﹤0.01% | 3796 |
|
|
2022
Q2 | $73K | Sell |
5,068
-3,282
| -39% | -$47.3K | ﹤0.01% | 3596 |
|
|
2022
Q1 | $157K | Buy |
+8,350
| New | +$157K | ﹤0.01% | 3457 |
|